carteolol has been researched along with Keratitis in 1 studies
Carteolol: A beta-adrenergic antagonist used as an anti-arrhythmia agent, an anti-angina agent, an antihypertensive agent, and an antiglaucoma agent.
Keratitis: Inflammation of the cornea.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Inoue, K | 1 |
| Okugawa, K | 1 |
| Kato, S | 1 |
| Inoue, Y | 1 |
| Tomita, G | 1 |
| Oshika, T | 1 |
| Amano, S | 1 |
1 other study available for carteolol and Keratitis
| Article | Year |
|---|---|
Ocular factors relevant to anti-glaucomatous eyedrop-related keratoepitheliopathy.
Topics: Adult; Aged; Aged, 80 and over; Antihypertensive Agents; Carteolol; Dinoprost; Drug Therapy, Combina | 2003 |